Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 15

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 15
---
 in this offering, representing
the difference between the assumed offering
price in this offering and our as adjusted net
tangible book value as of September 30, 2025. Furthermore,
if outstanding options
or warrants are exercised, outstanding restricted
stock units vest
or securities that are convertible or exercisable into
Common Stock are converted or exercised, you could experience
further dilution.

In addition,
we have a significant number of stock options and warrants outstanding,
and, in order to raise additional capital, we
may in the future offer additional shares
of our Common Stock or other securities convertible
into or exchangeable for our Common Stock at prices
that may not be the same as the price per
share in this offering. In the event that the outstanding options or warrants are exercised
or settled, or that we make additional
issuances of Common Stock or other convertible or exchangeable securities, you could experience
additional dilution. We cannot assure you that
we will be able to sell shares or other securities
in any other offering at a price per share that
is equal to or greater
than the price
per share paid by investors
in this offering, and investors purchasing shares
or other securities in the future could have rights
superior to existing stockholders, including investors
who purchase shares of Common Stock in this offering.
The price per share at which we sell additional shares of our Common Stock or securities convertible
or exercisable into Common Stock in future transactions, may be higher or lower than
the price per share you pay in this offering. As a result,
purchasers of the shares we sell in this offering,
as well as our existing stockholders, will experience
significant dilution if we sell at prices
significantly below the price at which they invested.
See the section entitled “D ilution”
below for a more detailed illustration of the dilution
you would incur if you participated in this offering.

<div align='center'>S-8</div>

The market price of our Common Stock has been vola tile and may cont inue to be volati le due to numerous circumstances beyond our control, and stockholders could lose a ll or part of their inv estment.

The market price of our Common Stock has been
and may continue to be highly volatile.
Our stock price could be subject
to wide fluctuations in response to a variety of factors,
including, without limitation:

| ● | future announcements about us, our collaborators,                                                
 or competitors, including the